A Toxicokinetic Study of Nickel-Induced Immunosuppression in Rats

Immunopharmacology and Immunotoxicology

Volumn 25, Issue 4, 2003, Pages 655-670

  Harkin, Andrew ^a   Hynes, Michael J ^a   Masterson, Eoghan ^a   Kelly, John P ^a   O'Donnell, James M ^a   Connor, Thomas J ^a,b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cytokine; Immune system; Immunosuppression; Lymphocytes; Macrophage; Nickel

Indexed keywords

CYTOKINE; INTERLEUKIN 10; NICKEL; NICKEL CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; HEAVY METAL POISONING; IMMUNE DEFICIENCY; IMMUNOTOXICITY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; TOXICOKINETICS;

ANIMALS; CONCANAVALIN A; CYTOKINES; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-10; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; NICKEL; RATS; RATS, SPRAGUE-DAWLEY; TH1 CELLS; TH2 CELLS;

ANIMALIA;

EID: 0345167008     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120026448     Document Type: Article

References (23)

1. Chang, L.W.; Magos, L.; Suzuki, T.; Nordberg, G.F.; Furst, A. Toxicology of Metals; Lewis Publishers, Inc, 1996; Vol. 1.
2. Smialowicz, R.J. Nickel. In Immunotoxicology of Environmental and Occupational Metals; Zelikoff, J.T., Thomas, P.T., Eds.; Taylor and Francis: London, 1998; 163-194.
3. Barret, R.D.; Bishara, S.E.; Quinn, J.K. Biodegradation of orthodontic appliances. Part 1 Biodegradation of nickel and chromium in vitro. Am. J. Orthod. Dentofacial Orthop. 1993, 103, 8-14.
4. Hildebrand, H.F.; Veron, C.; Martin, P. Nickel, chromium, cobalt alloys and allergic reactions: an overview. Biomaterials 1989, 10, 545-548.
5. Wataha, J.C.; Lockwood, P.E.; Marek, M.; Ghazi, M. Ability of Ni-containing biomedical alloys to activate monocytes and endothelial cells in vitro. J. Biomed. Mater. Res. 1999, 45, 251-257.
6. Wever, D.J.; Veldhuizen, A.G.; Sanders, M.M.; Schakenraad, J.M.; van Horn, J.R. Cytotoxic, allergic and genotoxic activity of a nickel-titanium alloy. Biomaterials 1997, 18, 1115-1119.
7. Coogan, T.P.; Latta, D.M.; Snow, E.T.; Costa, M. Toxicity and carcinogenicity of nickel compounds. Crit. Rev. Toxicol. 1989, 19, 341-384.
8. Pallardy, M.; Kerdine, S.; Lebrec, H. Testing strategies in immunotoxicology. Toxicol. Lett. 1998, 102-103, 257-260.
9. World Health Organization. Principles and methods for assessing direct immunotoxicity associated with exposure to chemicals. Environmental Health Criteria 1996, 180.
10. Mosmann, T.R.; Coffman, R.L.; TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 1989, 7, 145-173.
11. Beutler, B. TNF, immunity and inflammatory disease: lessons of the past decade. J. Invest. Med. 1995, 43, 227-235.
12. Tracey, K.J. Tumor necrosis factor-alpha. In The Cytokine Handbook, 2nd Ed.; Thompson, A., Ed.; Academic Press, 1994; 289-304.
13. Wong, G.H.W.; Goeddel, D.V. Tumor necrosis factor alpha and beta inhibit virus replication and synergize with interferons. Nature 1986, 323, 819-822.
14. Moore, K.W.; de Waal Malefyt, R.; Coffman, R.L.; O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19, 683-765.
15. Fasanmade, A.A.; Jusko, W.J. Optimizing the whole blood lymphocyte in the rat. J. Immunol. Meth. 1995, 184, 163-167.
16. Bayer, B.M.; Mulroney, S.E.; Hernandez, M.C.; Ding, X.Z. Acute infusions of cocaine result in time and dose-dependent effects on lymphocyte responses and corticosterone secretion in rats. Immunopharmacology 1995, 29, 19-28.
17. Pezzone, M.A.; Rush, K.A.; Kusnecov, A.W.; Wood, P.G.; Rabain, B.S. Corticosterone-independent alteration of lymphocyte mitogenic function by amphetamine. Brain Behav. Immunol. 1992, 6, 293-299.
18. DeGroote, D.; Zangerle, P.F.; Gevaert, Y.; Fassotte, M.F.; Beguin, Y.; Noizat-Pirenne, F.; Pirenne, G.; Gathy, R.; Lopez, M.; Dehart, I.; Igot, D.; Baudrihaye, M.; Delacroix, D.; Franchimont, P. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PMBC stimulation. Cytokine 1992, 4, 239-248.
19. Zangerle, P.F.; DeGroote, D.; Lopez, M.; Meuleman, R.J.; Vrindts, Y.; Fauchet, F.; Dehart, I.; Jadoul, M.; Radoux, D.; Franchimont, P. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IFN-γ and GM-CSF) in whole blood: II application to rheumatoid arthritis and osteoarthritis. Cytokine 1992, 4, 568-575.
20. Mellon, R.D.; Bayer, B.M. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses. J. Pharmacol. Expt. Ther. 1999, 288, 635-642.
21. McCoy, H.; Kenney, M.A. A review of biointeractions of Ni and Mg II. Immune system and oncology. Magnes. Res. 1992, 3, 223-232.
22. Connor, T.J.; Kelly, J.P.; Leonard, B.E. An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxymphetamine and fenfluramine on immunity in rats. Immunopharmacology 2000, 46, 223-235.
23. Connor, T.J.; Kelly, J.P. Methylenedioxymethamphetamine (MDMA; "Ecstasy") promotes an anti-inflammatory cytokine phenotype. Brain Behav. Immun. 2002, 16, 177.